Biotechnology - Oncology

Filter

Current filters:

Oncology

Popular Filters

1 to 25 of 646 results

Russia’s Biocad to invest $120 million in expansion of domestic operations

23-02-2015

Biocad, one of Russia’s largest biotech companies, has officially announced its plans to invest up…

AvastinBiocadBiosimilarsBiotechnologyFinancialHerceptinOncologyProductionRocheRussia

Foundation Medicine and H3 Biomedicine announce oncology collaboration

Foundation Medicine and H3 Biomedicine announce oncology collaboration

23-02-2015

USA-based Foundation Medicine and privately-held US biopharma company H3 Biomedicine have announced a…

BiotechnologyFoundation MedicineH3 BiomedicineOncologyResearchUSA

Roche likely to lose another state contract in Russia

Roche likely to lose another state contract in Russia

23-02-2015

Swiss pharma giant Roche will probably lose one of its major contracts in Russia for the next several…

AvastinBiocadBiosimilarsBiotechnologyMarkets & MarketingOncologyRocheRussia

European approval for expanded use of Celgene’s Revlimid

20-02-2015

US biotech firm Celgene’s European subsidiary has received approval from the European Commission for…

BiotechnologyCelgene CorpEuropeOncologyRegulationRevlimid

Genmab inks DuoBody deal with BioNovion in the field of immuno-oncology

19-02-2015

Danish biotech company Genmab has entered into a co-development and commercialization agreement with…

BioNovionBiotechnologyDuoBodyGenmabImmunologicalsLicensingOncologyResearch

Cell Medica starts commercial cell therapy manufacture in Germany

19-02-2015

UK-based cellular immunotherapy company Cell Medica has announced the start of commercial cell therapy…

BiotechnologyCell MedicaCytovir CMVOncologyProductionUK

US FDA expands use of Celgene’s Revlimid

18-02-2015

US biotech firm Celgene revealed that the US Food and Drug Administration has expanded the existing indication…

BiotechnologyCelgene CorpOncologyRegulationRevlimidUSA

Positive Ph III results for Navidea’s Lymphoseek in head and neck cancer

17-02-2015

US biotech firm Navidea Biopharmaceuticals today announced positive peer-reviewed publication of results…

BiotechnologyLymphoseekNavidea BiopharmaceuticalsOncologyResearch

US Orphan Drug status for Bexion’s Saposin C for glioblastoma

US Orphan Drug status for Bexion’s Saposin C for glioblastoma

17-02-2015

Privately-held US biotech firm Bexion Pharmaceuticals has received Orphan Drug designation for the US…

Bexion PharmaceuticalsBiotechnologyBXQ-350OncologyRegulationSaposin CUSA

Angle raises $11.2 million to aid development of Parsortix cancer cell filter

Angle raises $11.2 million to aid development of Parsortix cancer cell filter

16-02-2015

UK-based medtech company Angle has raised £7.3 million ($11.2 million) through issuing new shares. It…

AngleBiotechnologyErbituxFinancialOncologyResearch

Ono signs deal with Dako for Opdivo companion diagnostic test

Ono signs deal with Dako for Opdivo companion diagnostic test

16-02-2015

Japanese pharma company Ono Pharmaceutical and Danish diagnostic provider Dako have signed a new partnership…

BiotechnologyDakoJapanLicensingOncologyOno PharmaceuticalOpdivo

NICE final draft guidance does not recommend pomalidomide for blood cancer

NICE final draft guidance does not recommend pomalidomide for blood cancer

13-02-2015

The England medical costs watchdog the National Institute for Health and Care excellence (NICE) has issued…

BiotechnologyCelgene CorpImnovidOncologypomalidomidePricingRegulationUK

No new bidders emerge for Dendreon, so Valeant gets Provenge

No new bidders emerge for Dendreon, so Valeant gets Provenge

11-02-2015

US biotech firm Dendreon revealed yesterday that the bid deadline provided by the Court-approved bidding…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

Seattle Genetics posts losses but beats analyst forecasts

Seattle Genetics posts losses but beats analyst forecasts

11-02-2015

Bothell, Washington, USA-headquartered oncology specialist Seattle Genetics managed to beat analyst estimates…

AdcetrisBiotechnologyFinancialOncologySeattle GeneticsUSA

Celgene's Abraxane recommended by Scottish Medicines Consortium

Celgene's Abraxane recommended by Scottish Medicines Consortium

10-02-2015

The Scottish Medicines Consortium has decided to recommend Abraxane (paclitaxel) in combination with…

AbraxaneBiotechnologyCelgene CorpOncologyRegulationUK

European Commission approves added indication for Janssen’s Velcade, in MCL

European Commission approves added indication for Janssen’s Velcade, in MCL

06-02-2015

US health care giant Johnson & Johnson (NYSE: JNJ) subsidiary Janssen-Cilag International NV (Janssen)…

BiotechnologyEuropeJanssen-Cilag InternationalJohnson & JohnsonOncologyRegulationVelcade

Nano-carrier drugs for pancreatic cancer now being produced In China

06-02-2015

At the Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor…

BiotechnologyChinaOncologyResearch

Valeant to serve as “stalking horse bidder” in court-supervised Dendreon sales process

30-01-2015

US biotech firm Dendreon says it has reached an agreement with Canada’s Valeant Pharmaceuticals International…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

Strong cancer drug sales boost Celgene 4th-qtr and full-year 2014 results

Strong cancer drug sales boost Celgene 4th-qtr and full-year 2014 results

29-01-2015

US biotech firm Celgene posted 2014 financials before the markets opened this morning, showing that fourth…

AbraxaneBiotechnologyCelgene CorpFinancialOncologyRevlimid

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

29-01-2015

Photodynamic technology specialist Photocure has published data on a retrospective study showing Hexvix…

BiotechnologyHexvixOncologyPhotocureResearch

Dendreon extends deadline for qualified bids for the company

Dendreon extends deadline for qualified bids for the company

28-01-2015

US biotech firm Dendreon said yesterday that it would be extending the bid deadline for interested parties…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvenge

Kite Pharma expands CAR-T deal with Sourasky Medical Center

26-01-2015

US clinical-stage biopharma company Kite Pharma, focused on developing engineered autologous T cell therapy…

BiotechnologyKite PharmaOncologyResearch

Not for the faint of CAR-T: The CAR-T therapy landscape in 2015

22-01-2015

A new report shows investor enthusiasm for cancer-fighting CAR-T therapies is likely to continue despite…

BiotechnologyJuno TherapeuticsKite PharmaOncologyResearch

1 to 25 of 646 results

COMPANY SPOTLIGHT

Menarini

Back to top